3 d. ago Pentagon reliant on Chinese suppliers and ‘not prepared’ for war, report warns

The US defence industrial base remains dependent on Chinese suppliers despite efforts to decouple – and that raises concerns over war readiness, according to a report by data analytics firm Govini. Chinese firms still made up 9.3 per cent of the primary contractors, or Tier 1 suppliers, involved in major US defence programmes across nine critical sectors in 2024, Govini said in its annual National Security Scorecard. “The United States is not prepared for the war that we may have to enter if...

Events

4 d. ago Beijing Biostar Pharmaceuticals Resumes Trading on Hong Kong Stock Exchange

Beijing Biostar Pharmaceuticals Resumes Trading on Hong Kong Stock Exchange  TipRanks

Politics

4 d. ago Beijing Biostar Pharmaceuticals Reports 2024 Annual Results and Advances in Cancer Drug Development

Beijing Biostar Pharmaceuticals Reports 2024 Annual Results and Advances in Cancer Drug Development  TipRanks

Events

7 d. ago Beijing Biostar Pharmaceuticals Postpones Board Meeting to Finalize Annual Results

Beijing Biostar Pharmaceuticals Postpones Board Meeting to Finalize Annual Results  TipRanks

Politics

2 w. ago Beijing Biostar Pharmaceuticals to Discuss Annual Results and Dividend in Upcoming Board Meeting

Beijing Biostar Pharmaceuticals to Discuss Annual Results and Dividend in Upcoming Board Meeting  TipRanks

Politics

2 w. ago MingMed seeks Hong Kong listing to fund research and launch Botox alternative

MingMed Biotechnology is seeking a Hong Kong listing this year to raise funds to research and market a genetically engineered alternative to Botox in China. The drug developer, based in the Nansha district of Guangzhou, said it would set up an incubation centre in the Hong Kong Science and Technology Park in the third quarter. “Hong Kong has many good universities and research institutes, but it [does not have] a lot of innovative biotech firms,” said MingMed CEO Zhang Yan in an interview on...

Politics

2 w. ago China proposes shorter clinical trial reviews in efforts to accelerate drug development

China proposes shorter clinical trial reviews in efforts to accelerate drug development  Fierce Biotech

Events

4 w. ago China Becomes Source of New Cancer Treatments, in Threat to U.S. Drug Development

China Becomes Source of New Cancer Treatments, in Threat to U.S. Drug Development  Barron's

Events